메뉴 건너뛰기




Volumn 25, Issue 6, 2012, Pages 480-485

CORECT registry;Klinický registr CORECT

Author keywords

[No Author keywords available]

Indexed keywords

CANCER REGISTRY; REVIEW; ARTICLE; COLORECTAL TUMOR; HUMAN; REGISTER;

EID: 84872468595     PISSN: 0862495X     EISSN: 18025307     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (2)

References (7)
  • 2
    • 42949149159 scopus 로고    scopus 로고
    • Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer, a randomized phase III study
    • Saltz LB, Clarke S, Díaz-Rubio E et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer, a randomized phase III study. J Clin Oncol 2008; 26(12): 2013-2019.
    • (2008) J Clin Oncol , vol.26 , Issue.12 , pp. 2013-2019
    • Saltz, L.B.1    Clarke, S.2    Díaz-Rubio, E.3
  • 3
    • 68949094312 scopus 로고    scopus 로고
    • Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy
    • Kopetz S, Chang GJ, Overman MJ et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009; 27(22): 3677-3683.
    • (2009) J Clin Oncol , vol.27 , Issue.22 , pp. 3677-3683
    • Kopetz, S.1    Chang, G.J.2    Overman, M.J.3
  • 4
    • 79959338988 scopus 로고    scopus 로고
    • Survival for metastatic colorectal cancer in the bevacizumab era: A population-based analysis
    • Renouf DJ, Lim HJ, Speers C et al. Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysis. Clin Colorectal Cancer 2011; 10(2): 97-101.
    • (2011) Clin Colorectal Cancer , vol.10 , Issue.2 , pp. 97-101
    • Renouf, D.J.1    Lim, H.J.2    Speers, C.3
  • 5
    • 70349413045 scopus 로고    scopus 로고
    • Investigators of the BRiTE study Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: The BRiTE observational cohort study
    • Kozloff M, Yood MU, Berlin J et al. Investigators of the BRiTE study Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study. Oncologist 2009; 14(9): 862-870.
    • (2009) Oncologist , vol.14 , Issue.9 , pp. 862-870
    • Kozloff, M.1    Yood, M.U.2    Berlin, J.3
  • 7
    • 34147103678 scopus 로고    scopus 로고
    • Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy- refractory metastatic colorectal cancer
    • Van Cutsem E, Peeters M, Siena S et al. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol 2007; 25(13): 1658.
    • (2007) J Clin Oncol , vol.25 , Issue.13 , pp. 1658
    • Van Cutsem, E.1    Peeters, M.2    Siena, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.